pentobarbital

This page covers all pentobarbital drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting GABA-A receptor alpha-1/beta-2/gamma-2, GABA-A receptor alpha-1/beta-3/gamma-2, GABA-A receptor alpha-1/beta-3/gamma-2, GABA-A receptor alpha-2/beta-3/gamma-2, GABA-A receptor alpha-3/beta-3/gamma-2.

Targets

GABA-A receptor alpha-1/beta-2/gamma-2 · GABA-A receptor alpha-1/beta-3/gamma-2 · GABA-A receptor alpha-1/beta-3/gamma-2, GABA-A receptor alpha-2/beta-3/gamma-2, GABA-A receptor alpha-3/beta-3/gamma-2

Marketed (8)

• Nembutal Sodium · Oak Pharms · Neuroscience
• Amobarbitone · Neuroscience
• Cyclohexal · Neuroscience
• Thialpenton · Neuroscience
• Butenemal · Neuroscience
• Allonal · Neuroscience
• Metylfenemal · Neuroscience
• Barbidorm · Neuroscience

Phase 2 pipeline (4)

• Barbidal · Neuroscience
  Allobarbital works by enhancing the activity of neurotransmitters in the brain, leading to sedative and anticonvulsant effects.
• Ucedorm · Neuroscience
  Ucedorm works by affecting the activity of neurotransmitters in the brain, which can influence various physiological processes.
• Veronal · Neuroscience
  Veronal works by enhancing the effects of the neurotransmitter GABA, which helps to calm the brain and induce sleep.
• Censedal · Other
  Censedal is thought to work by modulating neural activity, but its exact mechanism of action is unclear.

Patent intelligence

• barbital patent landscape — aggregated cliff calendar, attackable patents, originator estates